US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

NCT00282295 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1344

Enrollment

INDUSTRY

Sponsor class

Conditions

Acellular Pertussis
Tetanus
Diphtheria

Interventions

BIOLOGICAL: Boostrix®
BIOLOGICAL: Menactra™

Sponsor

GlaxoSmithKline